BDBecton, Dickinson and Company BDX · NYSE
$195.74 -0.33% (-$0.65)
- Market cap
- $53.5B
- Enterprise value
- $69.6B
- P/E
- 56.8x
- Forward P/E
- 13.9x
- PEG
- -
- P/S
- 2.6x
- P/FCF
- 20.5x
- EV/EBITDA
- 17.9x
- ROIC
- 3.7%
- Gross margin
- 46.1%
- Net margin
- 4.5%
- Dividend yield
- 2.02%
- Payout ratio
- 115.1%
- Net debt/EBITDA
- 4.1x
- Beta
- 0.28
- Free float
- 99.8%
About the company
Becton, Dickinson and Company (BDX) is an American company operating in the field of healthcare technologies and medical devices. The company specializes in the development, manufacturing, and distribution of a wide range of products for diagnostics, therapy, and treatment in various healthcare areas. Its products include items such as needles, syringes, infectious disease diagnostic tests, diabetic products, and other medical devices. Becton, Dickinson and Company is known for its innovative technologies and high-quality products that contribute to improving patient care and enhancing the efficiency of medical procedures. The company operates globally and serves as a partner for healthcare institutions, hospitals, and medical professionals worldwide. Shares of Becton, Dickinson and Company (BDX) may represent an interesting investment opportunity for investors monitoring the healthcare sector and innovations in medical technologies.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Thomas E. Polen Jr.
Employees
72,000
Headquarters
Franklin Lakes
Valuation
Is today's price reasonable?
- What to watch: You pay 56.8 USD for 1 USD of yearly profit, a lot for its sector.
Growth and estimates
Is it growing, and what comes next?
- What to watch: Analysts expect revenue to fall by 12% this fiscal year.
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
- What speaks for it: Out of every 100 USD of revenue, 13 USD is left as free cash.
Financial health
Can it carry its debt?
- What to watch: Repaying its net debt would take 4.1 years of operating profit.
Capital and dividends
What does the company do with the money it earns?
- What speaks for it: It has raised its dividend 42 years in a row.
- What to watch: It pays out more in dividends than it earns: 115% of profit.
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number